ReviewDrug design, development and therapy2026
The Role of Microemulsions in Enhancing the Stability of Biopharmaceuticals.
Review in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biopharmaceuticals, especially protein- and nucleic acid-based drugs, have demonstrated remarkable therapeutic efficacy in the treatment of various diseases. However, their complex molecular structures make them prone to physical and chemical instabilities such as aggregation, degradation, and hydrolysis, which severely limit their clinical applications. Microemulsions, as thermodynamically stable and spontaneously formed nanoscale colloidal dispersion systems, have emerged as an effective strategy to improve the stability of biopharmaceuticals owing to their excellent encapsulation capacity, structural stability, and formulation flexibility. This review systematically summarizes the basic composition and structural characteristics of microemulsions, as well as their mechanisms in regulating drug release behavior. Using representative examples such as ketorolac, curcumin, resveratrol, and quercetin, it further analyzes the potential of microemulsions to enhance drug permeability, prolong pharmacological action, and improve therapeutic efficacy. In addition, the review discusses current technical challenges faced by microemulsion technology and explores its future prospects in targeted delivery and gene therapy applications, aiming to provide a theoretical basis and practical reference for microemulsion-based strategies to enhance the stability of biopharmaceuticals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.